Implications of Menopausal Hormone Therapy on Strabismus Incidence and Surgical Outcomes in Postmenopausal Women
Highlight
– Menopausal hormone therapy (MHT) increases the risk of strabismus diagnosis and related strabismus surgeries in menopausal women.
– No association was found between MHT and reoperation rates after primary strabismus surgery.
– The study used a large electronic health record cohort and rigorous time-varying Cox models to adjust for confounding factors.
– These findings suggest hormonal influences on ocular alignment mechanisms in postmenopausal women.
Study Background
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
